Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard Sherbaniuk
Clinical Experience With Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
Canadian Journal of Gastroenterology
Related publications
Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience
Przeglad Gastroenterologiczny
Gastroenterology
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Fulminant Legionellosis in Two Patients Treated With Infliximab for Crohn’s Disease: Case Series and Literature Review
Canadian Journal of Gastroenterology
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Individualized Treatment With Infliximab Therapy in Children With Crohn’s Disease Support Shorter Time Intervals Between Infusions
Journal of Drug Assessment
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Exclusive Enteral Nutrition Versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Comparison of Scheduled and Episodic Treatment Strategies of Infliximab in Crohn’s Disease
Gastroenterology
Hepatology
Gastroenterology
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
The Lancet
Medicine